These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 9914383)
1. Inhibition of the Mr 70,000 S6 kinase pathway by rapamycin results in chromosome malsegregation in yeast and mammalian cells. Bonatti S; Simili M; Galli A; Bagnato P; Pigullo S; Schiestl RH; Abbondandolo A Chromosoma; 1998 Dec; 107(6-7):498-506. PubMed ID: 9914383 [TBL] [Abstract][Full Text] [Related]
2. Altered centrosomes in ataxia-telangiectasia cells and rapamycin-treated Chinese hamster cells. Bonatti S; Simili M; Benedetti PA; Morandi F; Menichini P; Del Carratore R; Barale R; Abbondandolo A Environ Mol Mutagen; 2005 Oct; 46(3):164-73. PubMed ID: 15920752 [TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis and inhibition of signalling pathways by alkylated purines. Bonatti S; Pigullo S; Simili M; Abbondandolo A Mutagenesis; 2000 Jul; 15(4):361-6. PubMed ID: 10887217 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
6. Effects of rapamycin on cell proliferation and phosphorylation of mTOR and p70(S6K) in HepG2 and HepG2 cells overexpressing constitutively active Akt/PKB. Varma S; Khandelwal RL Biochim Biophys Acta; 2007 Jan; 1770(1):71-8. PubMed ID: 16952420 [TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of resistance to rapamycin in human cancer cells. Hosoi H; Dilling MB; Liu LN; Danks MK; Shikata T; Sekulic A; Abraham RT; Lawrence JC; Houghton PJ Mol Pharmacol; 1998 Nov; 54(5):815-24. PubMed ID: 9804616 [TBL] [Abstract][Full Text] [Related]
9. Acetaldehyde promotes rapamycin-dependent activation of p70(S6K) and glucose uptake despite inhibition of Akt and mTOR in dopaminergic SH-SY5Y human neuroblastoma cells. Fang CX; Yang X; Sreejayan N; Ren J Exp Neurol; 2007 Jan; 203(1):196-204. PubMed ID: 16962100 [TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 2A interacts with the 70-kDa S6 kinase and is activated by inhibition of FKBP12-rapamycinassociated protein. Peterson RT; Desai BN; Hardwick JS; Schreiber SL Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4438-42. PubMed ID: 10200280 [TBL] [Abstract][Full Text] [Related]
11. L-leucine availability regulates phosphatidylinositol 3-kinase, p70 S6 kinase and glycogen synthase kinase-3 activity in L6 muscle cells: evidence for the involvement of the mammalian target of rapamycin (mTOR) pathway in the L-leucine-induced up-regulation of system A amino acid transport. Peyrollier K; Hajduch E; Blair AS; Hyde R; Hundal HS Biochem J; 2000 Sep; 350 Pt 2(Pt 2):361-8. PubMed ID: 10947949 [TBL] [Abstract][Full Text] [Related]
12. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. Shima H; Pende M; Chen Y; Fumagalli S; Thomas G; Kozma SC EMBO J; 1998 Nov; 17(22):6649-59. PubMed ID: 9822608 [TBL] [Abstract][Full Text] [Related]
13. Targeted disruption of p70(s6k) defines its role in protein synthesis and rapamycin sensitivity. Kawasome H; Papst P; Webb S; Keller GM; Johnson GL; Gelfand EW; Terada N Proc Natl Acad Sci U S A; 1998 Apr; 95(9):5033-8. PubMed ID: 9560223 [TBL] [Abstract][Full Text] [Related]
14. Diethylsulphate and methylnitrosourea affect different targets in Chinese hamster fibroblasts: possible mechanisms of aneuploidy induction by these agents. Campagna M; Beffy P; Del Carratore R; Hauri L; Simi S; Bonatti S; Simili M Mutagenesis; 2003 Sep; 18(5):405-10. PubMed ID: 12960407 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action of the immunosuppressant rapamycin. Dumont FJ; Su Q Life Sci; 1996; 58(5):373-95. PubMed ID: 8594303 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin-resistant phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in v-SRC-transformed hamster fibroblasts. Tuhácková Z; Sovová V; Sloncová E; Proud CG Int J Cancer; 1999 Jun; 81(6):963-9. PubMed ID: 10362146 [TBL] [Abstract][Full Text] [Related]
17. Rapamycin inhibits cdk4 activation, p 21(WAF1/CIP1) expression and G1-phase progression in transformed mouse fibroblasts. Gaben AM; Saucier C; Bedin M; Barbu V; Mester J Int J Cancer; 2004 Jan; 108(2):200-6. PubMed ID: 14639603 [TBL] [Abstract][Full Text] [Related]
18. Spontaneous and induced aneuploidy, considerations which may influence chromosome malsegregation. Parry JM; Al-Obaidly A; Al-Walhaib M; Kayani M; Nabeel T; Strefford J; Parry EM Mutat Res; 2002 Jul; 504(1-2):119-29. PubMed ID: 12106652 [TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients. Peralba JM; DeGraffenried L; Friedrichs W; Fulcher L; Grünwald V; Weiss G; Hidalgo M Clin Cancer Res; 2003 Aug; 9(8):2887-92. PubMed ID: 12912932 [TBL] [Abstract][Full Text] [Related]
20. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Hidalgo M; Rowinsky EK Oncogene; 2000 Dec; 19(56):6680-6. PubMed ID: 11426655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]